These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12499181)

  • 41. Physiologically-based pharmacokinetic analysis of grepafloxacin.
    Nakajima Y; Hattori K; Shinsei M; Matsunaga N; Iizasa H; Sasabe H; Akiyama H; Miyanmoto G; Nakashima E
    Biol Pharm Bull; 2000 Sep; 23(9):1077-83. PubMed ID: 10993208
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Penetration of spectinomycin into cerebrospinal fluid duirng experimental meningitis.
    Delgado DG; Brau CJ; Avent CK
    Antimicrob Agents Chemother; 1980 Feb; 17(2):286-7. PubMed ID: 6446261
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacies of BMS 284756 against penicillin-sensitive, penicillin-resistant, and quinolone-resistant pneumococci in experimental meningitis.
    Cottagnoud P; Acosta F; Cottagnoud M; Pfister M; Täuber MG
    Antimicrob Agents Chemother; 2002 Jan; 46(1):184-7. PubMed ID: 11751131
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mathematical modelling of in situ and in vitro efflux of ciprofloxacin and grepafloxacin.
    Rodríguez-Ibáñez M; Sánchez-Castaño G; Montalar-Montero M; Garrigues TM; Bermejo M; Merino V
    Int J Pharm; 2006 Jan; 307(1):33-41. PubMed ID: 16257153
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Secretory mechanisms of grepafloxacin and levofloxacin in the human intestinal cell line caco-2.
    Yamaguchi H; Yano I; Hashimoto Y; Inui KI
    J Pharmacol Exp Ther; 2000 Oct; 295(1):360-6. PubMed ID: 10992002
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Population pharmacokinetics of moxifloxacin in plasma and bronchial secretions in patients with severe bronchopneumonia.
    Simon N; Sampol E; Albanese J; Martin C; Arvis P; Urien S; Lacarelle B; Bruguerolle B
    Clin Pharmacol Ther; 2003 Oct; 74(4):353-63. PubMed ID: 14534522
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of antimicrobial regimens for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.
    Friedland IR; Paris M; Ehrett S; Hickey S; Olsen K; McCracken GH
    Antimicrob Agents Chemother; 1993 Aug; 37(8):1630-6. PubMed ID: 8215275
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacokinetics of ciprofloxacin in pediatric cystic fibrosis patients.
    Schaefer HG; Stass H; Wedgwood J; Hampel B; Fischer C; Kuhlmann J; Schaad UB
    Antimicrob Agents Chemother; 1996 Jan; 40(1):29-34. PubMed ID: 8787874
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Grepafloxacin.
    Wagstaff AJ; Balfour JA
    Drugs; 1997 May; 53(5):817-24; discussion 825-7. PubMed ID: 9129868
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Involvement of multidrug resistance-associated protein 2 in intestinal secretion of grepafloxacin in rats.
    Naruhashi K; Tamai I; Inoue N; Muraoka H; Sai Y; Suzuki N; Tsuji A
    Antimicrob Agents Chemother; 2002 Feb; 46(2):344-9. PubMed ID: 11796340
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human THP-1 monocyte uptake and cellular disposition of 14C-grepafloxacin.
    Hall IH; Schwab UE; Ward ES; Rublein JC; Butts JD; Ives TJ
    J Infect Chemother; 2004 Feb; 10(1):11-8. PubMed ID: 14991512
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Influence of antibiotic dose, dosing interval, and duration of therapy on outcome in experimental pneumococcal meningitis in rabbits.
    Täuber MG; Kunz S; Zak O; Sande MA
    Antimicrob Agents Chemother; 1989 Apr; 33(4):418-23. PubMed ID: 2729936
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacokinetics and pharmacodynamics of oral grepafloxacin in patients with acute bacterial exacerbations of chronic bronchitis.
    Forrest A; Chodosh S; Amantea MA; Collins DA; Schentag JJ
    J Antimicrob Chemother; 1997 Dec; 40 Suppl A():45-57. PubMed ID: 9484873
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ocular penetration of grepafloxacin after intravitreal administration in albino and pigmented rabbits.
    Solans C; Bregante MA; Garcia MA; Perez S
    Chemotherapy; 2004 Jun; 50(3):133-7. PubMed ID: 15282440
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Application of terbium-sensitized luminescence for the determination of grepafloxacin in human urine and serum.
    Ocaña JA; Callejón M; Barragán FJ
    J Pharm Sci; 2001 Oct; 90(10):1553-7. PubMed ID: 11745713
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lower lipoteichoic and teichoic acid CSF concentrations during treatment of pneumococcal meningitis with non-bacteriolytic antibiotics than with ceftriaxone.
    Stuertz K; Schmidt H; Trostdorf F; Eiffert H; Mäder M; Nau R
    Scand J Infect Dis; 1999; 31(4):367-70. PubMed ID: 10528875
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rosaramicin versus penicillin G in experimental Pneumococcal meningitis.
    Nolan CM; Monson TP; Ulmer WC
    Antimicrob Agents Chemother; 1979 Dec; 16(6):776-80. PubMed ID: 43705
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differential uptake of grepafloxacin by human circulating blood neutrophils and those exudated into tissues.
    Niwa M; Hotta K; Kanamori Y; Matsuno H; Kozawa O; Hirota M; Uematsu T
    Eur J Pharmacol; 2001 Sep; 428(1):121-6. PubMed ID: 11779028
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diffusion of ofloxacin into the cerebrospinal fluid in patients with bacterial meningitis.
    Stahl JP; Croize J; Lefèbvre MA; Bru JP; Guyot A; Leduc D; Fourtillan JB; Micoud M
    Infection; 1986; 14 Suppl 4():S254-5. PubMed ID: 3469156
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Factors influencing the anti-inflammatory effect of dexamethasone therapy in experimental pneumococcal meningitis.
    Lutsar I; Friedland IR; Jafri HS; Wubbel L; Ahmed A; Trujillo M; McCoig CC; McCracken GH
    J Antimicrob Chemother; 2003 Oct; 52(4):651-5. PubMed ID: 12951330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.